• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Waters Corporation Announces CFO Transition

    12/3/20 6:59:00 AM ET
    $WAT
    $TXT
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Aerospace
    Industrials
    Get the next $WAT alert in real time by email

    MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) today announced that Sherry Buck will step down as Chief Financial Officer, effective December 31, 2020, in order to pursue another opportunity at a privately held company. Upon her departure, Michael F. Silveira, Vice President and Corporate Controller of Waters, will assume the role of interim Chief Financial Officer. Ms. Buck will work alongside Mr. Silveira in order to facilitate a smooth transition. Waters has been actively working with a leading search firm to identify a permanent CFO, and the process is advancing well with several strong internal and external candidates.

    “On behalf of the Board and management, I want to thank Sherry for her contributions to Waters over the last four years. I am also personally grateful for her help during my transition into Waters. Our dedicated and talented finance team is extremely well positioned to continue transforming the business and delivering on our objectives. We wish Sherry all the best in her next role,” commented Dr. Udit Batra, President and Chief Executive Officer of Waters Corporation. “We are pleased to have a leader of Mike’s caliber to serve as interim CFO. Throughout his 16 years at Waters, Mike has developed a deep understanding of our business, strategy and financial goals. The Board and I have the utmost confidence in Mike’s ability to focus on continued execution.”

    Mr. Silveira joined Waters in 2004 as Assistant Corporate Controller. He was appointed Vice President & Corporate Controller in 2013, and, in 2018, gained increased responsibilities including oversight of treasury, tax and corporate financial planning and analysis. He is a Certified Public Accountant and has held several senior financial management positions with Astro-Med, Inc (nka AstroNova), Textron, Inc. and KPMG. Mr. Silveira received a B.S. in Accounting from Providence College.

    About Waters

    Waters Corporation (NYSE:WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,000 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

    Cautionary Statement

    This release contains “forward-looking” statements regarding future results and events, including statements regarding Ms. Buck’s departure, the appointment of Mr. Silveira as interim chief financial officer and the process to find a permanent replacement for Ms. Buck. For this purpose, any statements that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “will,” “feels”, “believes”, “anticipates”, “plans”, “expects”, “intends”, “suggests”, “appears”, “estimates”, “projects”, and similar expressions, whether in the negative or affirmative, are intended to identify forward-looking statements. Actual future results and events may differ significantly from the results and events discussed in the forward-looking statements within this release for a variety of reasons, including the factors that are discussed in the sections entitled “Forward-Looking Statements” and “Risk Factors” of the Company’s annual report on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission (“SEC”), as updated by the Company’s subsequent filings with the SEC. The forward-looking statements included in this release represent the Company’s estimates or views as of the date of this release and should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this release. Except as required by law, the Company does not assume any obligation to update any forward-looking statements.

    Get the next $WAT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $WAT
    $TXT

    CompanyDatePrice TargetRatingAnalyst
    Textron Inc.
    $TXT
    7/1/2025$85.00Buy → Neutral
    Goldman
    Waters Corporation
    $WAT
    3/31/2025$460.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Waters Corporation
    $WAT
    3/26/2025$396.00 → $407.00Neutral → Outperform
    Robert W. Baird
    Waters Corporation
    $WAT
    2/13/2025$450.00Sector Perform → Sector Outperform
    Scotiabank
    Waters Corporation
    $WAT
    2/10/2025$360.00 → $415.00Underweight → Equal Weight
    Barclays
    Textron Inc.
    $TXT
    1/24/2025$110.00 → $85.00Buy → Neutral
    BofA Securities
    Waters Corporation
    $WAT
    1/10/2025$430.00Mkt Perform → Outperform
    Bernstein
    Textron Inc.
    $TXT
    1/6/2025$91.00Hold → Buy
    Vertical Research
    More analyst ratings

    $WAT
    $TXT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Knight Heather was granted 68 shares, increasing direct ownership by 11% to 681 units (SEC Form 4)

      4 - WATERS CORP /DE/ (0001000697) (Issuer)

      7/1/25 7:20:58 PM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Director Jiang Wei was granted 68 shares, increasing direct ownership by 3% to 2,479 units (SEC Form 4)

      4 - WATERS CORP /DE/ (0001000697) (Issuer)

      7/1/25 7:18:41 PM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SVP, Waters Division Carpio Robert L Iii covered exercise/tax liability with 134 shares, decreasing direct ownership by 5% to 2,656 units (SEC Form 4)

      4 - WATERS CORP /DE/ (0001000697) (Issuer)

      6/26/25 4:16:39 PM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $WAT
    $TXT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Fearon Richard H bought $332,900 worth of shares (1,000 units at $332.90), increasing direct ownership by 153% to 1,653 units (SEC Form 4)

      4 - WATERS CORP /DE/ (0001000697) (Issuer)

      5/29/24 11:23:35 AM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $WAT
    $TXT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions

      The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for el

      7/15/25 12:05:00 PM ET
      $TXT
      Aerospace
      Industrials
    • Cessna Skyhawk Soars With Enhanced Efficiency: Solid-State Dual Electronic Ignition System Introduced to the Industry-leading Piston

      The industry-leading training aircraft, the Cessna Skyhawk, now features a dual electronic ignition system (dual EIS), enhancing maintenance, efficiency and overall operation of the single-engine, high-wing piston. The dual Lycoming electronic ignition system is now standard on all new Cessna Skyhawk aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714759359/en/Cessna Skyhawk soars with enhanced efficiency: solid-state dual electronic ignition system introduced to the industry-leading piston (Photo Credit: Textron Aviation) The Cessna Skyhawk is designed and produced by Textron Aviation Inc., a Textron Inc. (NYSE:TXT)

      7/14/25 12:00:00 PM ET
      $TXT
      Aerospace
      Industrials
    • Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

      Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to approximately $40 billion, with 5-7% annual growthCreates a combined company with pro forma expected 2025 sales of approximately $6.5 billion and adjusted EBITDA of approximately $2.0 billion Increases annual recurring revenue to over 70% with over 80% of revenue coming from iconic market-leading brandsAnticipate approximately $345 million in annualized EBITDA synergies by 2030, including $200 million of cost synergies by year three, and $290 million of revenue synergies by year five  Delivers a

      7/14/25 6:15:00 AM ET
      $BDX
      $WAT
      Medical/Dental Instruments
      Health Care
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $WAT
    $TXT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Textron downgraded by Goldman with a new price target

      Goldman downgraded Textron from Buy to Neutral and set a new price target of $85.00

      7/1/25 8:16:03 AM ET
      $TXT
      Aerospace
      Industrials
    • Waters upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded Waters from Sector Weight to Overweight and set a new price target of $460.00

      3/31/25 7:57:55 AM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Waters upgraded by Robert W. Baird with a new price target

      Robert W. Baird upgraded Waters from Neutral to Outperform and set a new price target of $407.00 from $396.00 previously

      3/26/25 7:47:54 AM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $WAT
    $TXT
    SEC Filings

    See more
    • SEC Form 425 filed by Waters Corporation

      425 - WATERS CORP /DE/ (0001000697) (Subject)

      7/14/25 5:25:11 PM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 425 filed by Waters Corporation

      425 - WATERS CORP /DE/ (0001000697) (Subject)

      7/14/25 5:23:10 PM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 425 filed by Waters Corporation

      425 - WATERS CORP /DE/ (0001000697) (Subject)

      7/14/25 5:18:16 PM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $WAT
    $TXT
    Financials

    Live finance-specific insights

    See more
    • Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

      Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to approximately $40 billion, with 5-7% annual growthCreates a combined company with pro forma expected 2025 sales of approximately $6.5 billion and adjusted EBITDA of approximately $2.0 billion Increases annual recurring revenue to over 70% with over 80% of revenue coming from iconic market-leading brandsAnticipate approximately $345 million in annualized EBITDA synergies by 2030, including $200 million of cost synergies by year three, and $290 million of revenue synergies by year five  Delivers a

      7/14/25 6:15:00 AM ET
      $BDX
      $WAT
      Medical/Dental Instruments
      Health Care
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call

      MILFORD, Mass., July 11, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2025 financial results conference call on Monday, August 4th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least September 2nd, 2025, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of

      7/11/25 4:15:00 PM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Textron to Release Second Quarter Results on July 24, 2025

      Textron Inc. (NYSE:TXT) will release its second quarter 2025 financial results on Thursday morning, July 24, 2025. Textron will also host a conference call at 8:00 a.m. (Eastern) to discuss the results and the company's outlook. The call will be available via webcast at www.textron.com or by direct dial at (833) 470-1428 in the U.S. or (929) 526-1599 outside of the U.S.; Access Code: 626840. In addition, the call will be recorded and available for playback beginning at 11:00 a.m. (Eastern) on Thursday, July 24, 2025 by dialing (866) 813-9403; Access Code: 942127. About Textron Inc. Textron Inc. is a multi-industry company that leverages its global network of aircraft, defense, indus

      6/24/25 9:30:00 AM ET
      $TXT
      Aerospace
      Industrials

    $WAT
    $TXT
    Leadership Updates

    Live Leadership Updates

    See more
    • Helios Technologies Appoints Ian Walsh to Board of Directors

      Expands Board back to seven members Helios Technologies, Inc. (NYSE:HLIO) ("Helios" or the "Company"), a global leader in highly engineered motion control and electronic control technologies, today announced that its Board of Directors (the "Board") has appointed Ian Walsh to serve as director, effective June 5, 2025. He will serve as a member of the class of directors whose term will expire at the 2026 Annual Meeting of Shareholders. The Board also appointed Mr. Walsh to serve on the Board's Audit Committee and Governance Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250611101051/en/Mr. Ian Walsh brings 35 years o

      6/11/25 4:15:00 PM ET
      $HLIO
      $KAMN
      $REVG
      $TXT
      Metal Fabrications
      Industrials
      Military/Government/Technical
      Auto Manufacturing
    • Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio

      MILFORD, Mass., May 21, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies. The Aura™ platform from Halo Labs features a highly differentiated technology that performs full spectrum particle analysis and is complementary to the Waters light scattering detection solutions from its Wyatt Technology™ Portfolio. For example, its subvisible particle technology unlocks additional insights when characterizing external particles used to amplify CAR T-cells for cell therapy,

      5/21/25 8:00:00 AM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Textron Aviation Calls on Cessna, Beechcraft and Hawker Owners to Transport Athletes to the 2026 Special Olympics USA Games

      Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the coordination of the ninth Special Olympics Airlift, a monumental event aimed at transporting hundreds of athletes and coaches across country to the 2026 Special Olympics USA Games in Minnesota's Twin Cities. The company is calling on Cessna, Beechcraft and Hawker aircraft owners and operators to come together on Friday, June 19, 2026, and Saturday, June 27, 2026, to enable champions from all corners of the nation to travel to and from the host city, regardless of financial or logistical challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2025043081

      5/1/25 11:31:00 AM ET
      $TXT
      Aerospace
      Industrials

    $WAT
    $TXT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Textron Inc.

      SC 13G/A - TEXTRON INC (0000217346) (Subject)

      11/14/24 1:28:29 PM ET
      $TXT
      Aerospace
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Waters Corporation

      SC 13G/A - WATERS CORP /DE/ (0001000697) (Subject)

      11/12/24 11:54:03 AM ET
      $WAT
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Textron Inc. (Amendment)

      SC 13G/A - TEXTRON INC (0000217346) (Subject)

      2/14/24 10:04:34 AM ET
      $TXT
      Aerospace
      Industrials